CC
EW icon

ClearArc Capital’s Edwards Lifesciences EW Stock Holding History

ClearArc Capital’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$519K Sell
6,678
-2,685
-29% -$210K 0.2% 125
2019
Q3 		$686K Buy
9,363
+33
+0.4% +$2.32K 0.2% 129
2019
Q2 		$575K Sell
9,330
-1,146
-11% -$69.3K 0.17% 149
2019
Q1 		$668K Sell
10,476
-285
-3% -$16.3K 0.18% 137
2018
Q4 		$549K Sell
10,761
-5,544
-34% -$281K 0.16% 150
2018
Q3 		$946K Buy
16,305
+177
+1% +$8.66K 0.12% 166
2018
Q2 		$783K Sell
16,128
-18
-0.1% -$840 0.11% 190
2018
Q1 		$751K Buy
16,146
+57
+0.4% +$2.48K 0.11% 192
2017
Q4 		$604K Sell
16,089
-228
-1% -$8.37K 0.08% 237
2017
Q3 		$595K Buy
16,317
+834
+5% +$31.8K 0.09% 238
2017
Q2 		$610K Sell
15,483
-108
-0.7% -$3.94K 0.1% 218
2017
Q1 		$489K Sell
15,591
-21
-0.1% -$657 0.08% 251
2016
Q4 		$488K Sell
15,612
-81
-0.5% -$2.62K 0.09% 239
2016
Q3 		$631K Buy
15,693
+207
+1% +$7.8K 0.12% 191
2016
Q2 		$515K Sell
15,486
-252
-2% -$8.62K 0.1% 224
2016
Q1 		$463K Sell
15,738
-144
-0.9% -$3.97K 0.1% 241
2015
Q4 		$418K Buy
15,882
+318
+2% +$8.26K 0.09% 264
2015
Q3 		$369K Sell
15,564
-420
-3% -$10.1K 0.08% 295
2015
Q2 		$379K Buy
15,984
+2,022
+14% +$45.6K 0.07% 311
2015
Q1 		$332K Buy
13,962
+180
+1% +$4.04K 0.07% 309
2014
Q4 		$293K Buy
13,782
+702
+5% +$14.1K 0.06% 332
2014
Q3 		$223K Buy
+13,080
New +$206K 0.05% 364

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ClearArc Capital's EW Position: Q4 2019 in Review

ClearArc Capital reduced its Edwards Lifesciences (EW) stake by 29% in Q4 2019, selling an estimated $210K and leaving 6,678 shares worth $519K. The position accounts for 0.2% of the portfolio, ranked #125.

ClearArc Capital first reported a position in EW in Q3 2014 and has held it in 22 quarters since. The position peaked at $946K in Q3 2018. 1,093 funds tracked by Wall St. Rank hold EW as of Q4 2019.

  • ClearArc Capital held 6,678 shares of Edwards Lifesciences worth $519K as of Q4 2019.
  • ClearArc Capital sold 2,685 Edwards Lifesciences shares in Q4 2019, an estimated $210K.
  • Edwards Lifesciences made up 0.2% of ClearArc Capital's portfolio in Q4 2019, its #125 holding.
  • ClearArc Capital first reported a position in Edwards Lifesciences in Q3 2014 and has held it in 22 quarters since.
  • ClearArc Capital's Edwards Lifesciences position peaked at $946K in Q3 2018.
  • 1,093 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2019.

Based on ClearArc Capital's 13F filing for Q4 2019, filed 14 Feb 2020.